Comprehensive Medical Management of Peripheral Arterial Disease

被引：19

作者：

Gandhi, Sanjay ^{[1
]}

Weinberg, Ido ^{[1
]}

Margey, Ronan ^{[1
]}

Jaff, Michael R. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Cardiovasc Med, Sect Vasc Med, Boston, MA 02114 USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 2011年 / 54卷 / 01期

关键词：

Peripheral arterial disease; Medical therapy; ANKLE BRACHIAL INDEX; INTERMITTENT CLAUDICATION; CARDIOVASCULAR EVENTS; DOUBLE-BLIND; AUTOLOGOUS TRANSPLANTATION; THERAPEUTIC ANGIOGENESIS; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; DIABETIC-PATIENTS; WALKING DISTANCE;

D O I：

10.1016/j.pcad.2011.02.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Peripheral arterial disease (PAD) is highly prevalent and is associated with high morbidity and mortality. The medical management of PAD involves a comprehensive approach to the patient with emphasis on cardiovascular risk factor modification in addition to therapies directed at treatment of limb symptoms. This manuscript will review the current status of medical therapy in management of patients with PAD. (Prog Cardiovasc Dis 2011;54:2-13) (C) 2011 Elsevier Inc. All rights reserved.

引用

页码：2 / 13

页数：12

共 111 条

[1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].

Adler, AI ;

Stratton, IM ;

Neil, HAW ;

Yudkin, JS ;

Matthews, DR ;

Cull, CA ;

Wright, AD ;

Turner, RC ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419

[2]

Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]

[3]

Anand S, 2007, NEW ENGL J MED, V357, P217

[4]

[Anonymous], 2011, Cochrane Database Syst Rev 2003, DOI DOI 10.1002/14651858.CD000535

[5] Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: A randomized, double-blind, placebo-controlled trial [J].

Arosio, E ;

De Marchi, S ;

Zannoni, M ;

Prior, M ;

Lechi, A .

MAYO CLINIC PROCEEDINGS, 2002, 77 (08) :754-759

[6]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[7] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].

Baumgartner, I ;

Pieczek, A ;

Manor, O ;

Blair, R ;

Kearney, M ;

Walsh, K ;

Isner, JM .

CIRCULATION, 1998, 97 (12) :1114-1123

[8] Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].

Beckman, JA ;

Creager, MA ;

Libby, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581

[9] The nonlipid effects of statins on endothelial function [J].

Beckman, Joshua A. ;

Creager, Mark A. .

TRENDS IN CARDIOVASCULAR MEDICINE, 2006, 16 (05) :156-162

[10] The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease [J].

Belch, Jill ;

MacCuish, Angus ;

Campbell, Iain ;

Cobbe, Stuart ;

Taylor, Roy ;

Prescott, Robin ;

Lee, Robert ;

Bancroft, Jean ;

MacEwan, Shirley ;

Shepherd, James ;

Macfarlane, Peter ;

Morris, Andrew ;

Jung, Roland ;

Kelly, Christopher ;

Connacher, Alan ;

Peden, Norman ;

Jamieson, Andrew ;

Matthews, David ;

Leese, Graeme ;

McKnight, John ;

O'Brien, Iain ;

Semple, Colin ;

Petrie, John ;

Gordon, Derek ;

Pringle, Stuart ;

MacWalter, Ron .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :a1840

← 1 2 3 4 5 6 7 8 9 10 →